VolitionRX Ltd. (NYSE: VNRX) Starts Presentation at 12th Annual LD Micro Main Event
VolitionRX (NYSE: VNRX) is a multi-national company developing simple, easy to use, cost effective blood tests to accurately diagnose a range of cancers and other diseases. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluids to indicate if disease is present. Volition is primarily focused on human diagnostics but also has a majority-owned subsidiary focused on animal diagnostics. Volition's research and development activities are centered in Belgium, with additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products…







